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Abstract 
Case report on a first case of adult secondary acute 
myeloid leukemia with the recurrent KMT2A-GAS7 
fusion. 
Clinics 
Age and sex 
71 years old at diagnosis of acute myeloid leukemia 
(AML) in December 2006.male patient. 
Previous history 
Preleukemia Chronic myeloproliferative neoplasm : 
Primary myelofibrosis was diagnosed in 2005. The 
patient was treated with Hydroxyurea from January 
2005 to March 2007; no previous malignancy; no 
inborn condition of note  
Organomegaly 
Hepatomegaly , splenomegaly , no enlarged lymph 
nodes , no central nervous system involvement   
Blood 
WBC: 32.4 X 109/l 
HB: Not available 
Platelets: Not available 
Blasts: 70% 




Acute myeloid leukaemia, not otherwise specified 
(WHO 2008). 
Immunophenotype 
HLADR: 20%, CD117: 93%, CD34: 10%, CD33: 
50%, CD13: 95%, CD36: 30%, CD56: 13%, CD14: 
6%, CD15: 7%, CD7: 21%, CD3: 2%, CD10: 3%, 
CD19: 0%, CD20: 6%. 
Survival 
Date of diagnosis 
12-2006 
Treatment 
Palliative care: treatment with Hydroxyurea 
Complete remission: no 
Treatment related death: no 
Status Dead 
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Other molecular cytogenetics technics 
FISH (Fluorescent In Situ Hybridization); VYSIS 
LSI MLL Dual-color, Break-apart rearrangement 
probe (Abbott Molecular Inc., Des Plaines, IL). BAC 
(Bacterial artificial chromosome) probe RP11-
952P13 covering the GAS7 gene 
(http://genome.ucsc.edu) 
Other molecular cytogenetics results 
FISH experiments were performed on metaphasic 
and interphasic cells with the commercial MLL 
probe. Analysis showed a KMT2A/MLL 
rearrangement in 98% of 200 interphasic nuclei and 
confirmed the t(11;17) translocation (Figure 2A).  
FISH analysis with the RP11-952P13 BAC probe 
revealed a GAS7 rearrangement. Hybridization 
signals on metaphasic chromosomes were detected 
on normal chromosome 17 and on derivative 
chromosomes 11 and 17 (Figure 2B). 
Other Molecular Studies 
Technics: 
RNA extraction, RT-PCR and standard sequencing 
Primers:  
-KMT2A forward primer: 
5'ACCACTCCTAGTGAGCCCAAGAAA 3' 
located in KMT2A exon 7  
-GAS7 reverse primer: 
3'TGGTCTCATTGGTGGTCGTGTTGA5' located 
in GAS7 exon 2-3. 
 
Figure 1. GTG-banded Karyotype. GTG-banded 
karyotype of leukemic cells showing the t(11;17)(q23;p13) 
translocation. Arrows indicate the derivative chromosomes 
der(11) and der(17). 
 
Figure. 2. Fluorescence in situ hybridization (FISH) 
analysis of the t(11;17) positive cells. (A) FISH with the 
LSI MLL dual-color, break-apart rearrangement probe 
showing the MLL rearrangement. The fusion signal is 
located on the normal chromosome 11, the green signal, 
centromeric part of the probe, is detected on the derivative 
chromosome der(11) and the red signal, telomeric part of 
the probe, is detected on the derivative chromosome 
der(17). (B) FISH with RP11-952P13 probe showing 
rearrangement of GAS7. A normal signal is detected on 
chromosome 17, and a split signal is visualized on both 
derivative chromosomes der(17) and der(11). 
 
Figure. 3. Analysis of the KMT2A-GAS7 transcripts. (A) 
PCR products obtained by Reverse-Transcriptase 
Polymerase Chain Reaction (RT-PCR). M, 1Kb DNA 
marker; lane 1, KMT2A/MLL-GAS7 cDNA fragments 
generated by KMT2A-FW-exon7 and GAS7-RV-exon2-3 
primers. Arrows indicate the two 300bp and 220bp 
amplified KMT2A-GAS7 transcripts. (B) Chromatogram 
showing partial nucleotide sequences of the two KMT2A-
GAS7 transcripts. The arrows indicate the breakpoints of 
the KMT2A/MLL-GAS7 fusion. 
Results: 
Two KMT2A-GAS7 fusion transcripts were 
detected (Figure 3A). Sequence analysis of these 
transcripts revealed an in-frame fusion between 
KMT2A exon 8 and GAS7 exon 2 for the 
predominant transcript (transcript 1), and KMT2A 
exon 7 and GAS7 exon 2 for the second transcript 
(transcript 2) (Figure 3B). 
Other Findings 
The t(11;17)(q23;p13) translocation generates a 
KMT2A/MLL-GAS7 in-frame fusion transcript 
which encodes a putative chimeric protein.  
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Figure 4. Schematic representation of KMT2A, GAS7 and the predicted KMT2A-GAS7 fusion proteins. The predicted 
KMT2A-GAS7 chimeric protein contains AT-Hook domains (ATH1-3), speckled nuclear localization1,2 (SNL1,2) and DNA 
methyltransferase (MT) domains followed by full-length GAS7 containing WW domain and F-bar dimerization module with FCH 
domain and Coiled coil region. Abbreviations: SET (Su(var)3-9, Enhancer-of-zeste, Trithorax) domain with histone H3K4 
methyltransferase activity, FCH: FER-CIP4 Homology 
.
The N-terminal region of the KMT2A protein 
including the AT-hooks, speckled nuclear 
localization signals 1 and 2 motifs, and DNA 
methyltransferase domains, is fused to almost the 
entire GAS7 protein, containing WW domain and F-
bar dimerization module with a FER-CIP4 
Homology (FCH) domain and a coiled coil region 
domain (Figure 4). The predicted GAS7 domains are 
based on NCBI search for conserved domains within 




This case represents the first case of adult leukemia 
associated to the KMT2A-GAS7 fusion. GAS7 is a 
rare recurrent fusion partner of KMT2A. To our 
knowledge, only two cases with this fusion have 
been reported in the literature, in pediatric and infant 
leukemias. The first case was identified in a 14-year-
old boy with a therapy-related AML, after DNA 
topoisomerase II inhibitor treatment for a 
neuroblastoma. The patient died 4 months after 
diagnosis (Megonigal MD et al, 2000). The second 
case was identified in a 15-month-old girl with a de 
novo B-cell acute lymphoblastic leukemia. This 
patient was in remission 14 months after diagnosis 
(Panagopoulos I et al, 2006). Additionally, the 
translocation t(11;17)(q23;p13) was reported, 
without molecular characterization, in few studies 
(Chessells JM et al, 2002 and Stark B et al, 1989).  
The adult patient described here was treated with a 
palliative approach because of comorbidities and he  
 
died 3 months after the diagnosis of AML.  
This specimen was sequenced (RNA sequencing) as 
part of the Leucegene project (Nature Genet 2015). 
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